Dr. Channing Paller, MD
Claim this profileSibley Memorial Hospital
Expert in Prostate Cancer
Studies Squamous Cell Carcinoma
12 reported clinical trials
25 drugs studied
Area of expertise
1Prostate Cancer
Global LeaderStage IV
Stage I
Stage II
2Squamous Cell Carcinoma
Affiliated Hospitals
Clinical Trials Channing Paller, MD is currently running
Whole-Food Plant-Based Diet
for Prostate Cancer
The study is comparing the effect on weight of providing home-delivered whole-food, plant-based meals versus standard, general nutritional counseling to men with prostate cancer on androgen-deprivation therapy (ADT).
Recruiting1 award N/A13 criteria
Genetic Testing
for Prostate Cancer
PROMISE aims to create a comprehensive nationwide registry of prostate cancer patients with germline pathogenic variants by prospectively screening approximately 5,000 subjects with a confirmed prostate cancer diagnosis, either through tissue biopsy, PSA greater than 100 ng/dL and/or radiographic evidence of disease and receiving systemic therapy for prostate cancer. Patients at all stages of disease will be welcome to participate in the PROMISE Registry. Participants will be recruited \& screened over a five-year period. Study participants will be asked to provide a saliva sample to be tested for germline cancer risk variants through Color Health. If the results identify a pathogenic or likely pathogenic variant, an appointment with a genetic counselor from Color Health will be scheduled to discuss the results. Participants will complete a baseline demographic survey that includes self-reported health history, family history of cancer and standardized patient reported outcome (PRO) measures. PROMISE Registry staff will request medical records from the participant's cancer care provider(s) for the purpose of obtaining clinical data. Participants will receive bi-annual newsletters offering information on new developments in treatment and research opportunities, including clinical trials, associated with genetic variants. Eligible participants (those with target germline mutations) will be followed every 6 months to obtain updated health records data and patient-reported outcomes data. Participants will be followed for a minimum of 15 years. The PROMISE registry will help identify prostate cancer patients with pathogenic variants to learn more about how these variants affect patient outcomes. Ultimately, we hope to help patients learn more about their disease and the treatments that they may derive the most benefit from, including the germline genetic biomarker-based clinical trials they may be eligible for. For more information, visit the study website at: prostatecancerpromise.org
Recruiting1 award N/A2 criteria
More about Channing Paller, MD
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Channing Paller, MD has experience with
- Olaparib
- Prednisone
- Enzalutamide
- LY2157299
- Vitamin C
- Stereotactic Ablative Radiotherapy (SABR)
Breakdown of trials Channing Paller, MD has run
Prostate Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Channing Paller, MD specialize in?
Channing Paller, MD focuses on Prostate Cancer and Squamous Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are Stage I.
Is Channing Paller, MD currently recruiting for clinical trials?
Yes, Channing Paller, MD is currently recruiting for 3 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Channing Paller, MD has studied deeply?
Yes, Channing Paller, MD has studied treatments such as Olaparib, Prednisone, Enzalutamide.
What is the best way to schedule an appointment with Channing Paller, MD?
Apply for one of the trials that Channing Paller, MD is conducting.
What is the office address of Channing Paller, MD?
The office of Channing Paller, MD is located at: Sibley Memorial Hospital, Washington, District of Columbia 20016 United States. This is the address for their practice at the Sibley Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.